Misoprostol Induced Convulsion-A Rare Side Effect of Misoprostol

Misoprostol Induced Convulsion-A Rare Side Effect of Misoprostol

Misoprostol, a synthetic prostaglandin E1 has wider application in obstetrics gynaecology. It has been recommended in the prophylaxis and treatment of Post Partum Haemorrhage (PPH) by Federation of Obstetrics and Gynaecology (FIGO), World Health Organisation (WHO) and American College of Obstetric...

Full description

Bibliographic Details
Main Authors:	Nalini Sharma, Rituparna Das, Santa Singh Ahanthem, Kalyani Reddy
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2017-02-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	hyperpyrexia prostaglandin e1 postparum haemorrhage
Online Access:	https://jcdr.net/articles/PDF/9189/23396_CE(Ra)_F(AK)_PF1(P_HJ)_PFA(NC)_PF2(AG_OM).pdf

Similar Items

Sublingual misoprostol and hyperpyrexia: case report with temperature curve
by: Paul Nkemtendong Tolefac, et al.
Published: (2017-07-01)

A rare case of misoprostol hypersensitivity
by: Rituparna Das, et al.
Published: (2022-01-01)

Different Time Schedules of Mifepristone and Misoprostol in Second Trimester Medical Abortion: A Comparative Study
by: Nalini Sharma, et al.
Published: (2017-07-01)

Termination of Pregnancy: Misoprostol Versus Prostaglandin E2
by: Imama Tul Bushra, et al.
Published: (2023-12-01)

Sublingual misoprostol allergy: A case report
by: Ezema Evaristus Chinonye, et al.
Published: (2019-01-01)

Detecting awareness rate of midwifery students a bout the prenatal, intrapartal and post partal care of women suffering from AIDS in nursing and midwifery faculties in medical university of health and medical teaching in Teehran (1993).
by: Fereshteh jahdy
Published: (1996-05-01)

LABOUR INDUCTION WITH ORAL MISOPROSTOL IN PRE LABOUR RUPTURE OF MEMBRANES AT TERM
by: Umber Fatima, et al.
Published: (2013-06-01)

Dyskinesia-hyperpyrexia syndrome in Parkinson's disease triggered by overdose of levodopa — a case report and literature review
by: Xiangnan Du, et al.
Published: (2024-01-01)

To study the efficacy of misoprostol compared with methyl ergometrine for prevention of postpartum haemorrhage
by: Varsha Kotwal
Published: (2019-07-01)

Comparison of Vaginal and Oral Doses of Misoprostol for Labour Induction in Post-Term Pregnancies
by: Masomeh Rezaie, et al.
Published: (2016-03-01)

Parental Perception of Fever in Children
by: Mohammed , J Al-Khalidy, et al.
Published: (2007-06-01)

Comparison of the Effects of Estradiol Cream and Vaginal Misoprostol Suppository on Cervical Preparation
by: jila agah, et al.
Published: (2023-05-01)

Efficacy of Misoprostol versus Syntometrine in the Prevention of Postpartum Hemorrhage
by: Sehrana Kousar
Published: (2010-06-01)

Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol
by: Wan-Hua Ting, et al.
Published: (2015-08-01)

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi
by: Nhomsai Hagen, et al.
Published: (2020-03-01)

Temperature management using an intervascular cooling device for a COVID‐19 patient with refractory hyperthermia
by: Yuya Yoshino, et al.
Published: (2023-04-01)

A Patient with Recurrent Dyskinesia and Hyperpyrexia Syndrome
by: Min Seok Baek, et al.
Published: (2017-09-01)

Comparing intravenous oxytocin Vs. rectal misoprostol for third-stage management after second-trimester medically induced abortion
by: Amirabi A, et al.
Published: (2012-09-01)

Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
by: Hashima-E- Nasreen, et al.
Published: (2011-08-01)

Serotonin syndrome: a rare undiagnosed cause of hyperpyrexia
by: Hamdy Ibrahim, et al.
Published: (2023-06-01)

Low-dose Misoprostol for Second Trimester Pregnancy Termination in Women with a Prior Caesarean Delivery
by: Emine Aydin, et al.
Published: (2019-11-01)

Women satisfaction on choosing the cervical ripening method: Oral misoprostol versus balloon catheter
by: Emeline Flament, et al.
Published: (2023-09-01)

Misoprostol versus oxytocin for labor induction in term and post-term pregnancy: randomized controlled trial
by: Márcia Maria Auxiliadora de Aquino, et al.

Parkinsonism-hyperpyrexia, a rare consequence of deep brain stimulator malfunction in advanced Parkinson’s disease
by: Manuel Díaz Castela, et al.
Published: (2024-01-01)

Hyperpyrexia associated with congenital Long QT Syndrome
by: Nuriye Tarakci, et al.
Published: (2014-08-01)

Parkinsonism Hyperpyrexia Syndrome Mimicking Fever of Unknown Origin in Advanced Parkinson’s Disease Patient
by: Saeromi Kim, et al.
Published: (2015-12-01)

Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study
by: Kate Reiss, et al.
Published: (2017-07-01)

Hyperpyrexia in a previously healthy pregnant female with COVID pneumonia: a case report and review of the literature
by: Nipun Lakshitha de Silva, et al.
Published: (2023-06-01)

Determination of Prostaglandins (Carboprost, Cloprostenol, Dinoprost, Dinoprostone, Misoprostol, Sulprostone) by UHPLC-MS/MS in Toxicological Investigations
by: Paweł Szpot, et al.
Published: (2023-09-01)

Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial
by: Mariam Dawoud, et al.
Published: (2023-08-01)

Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death
by: Damyanti Sharma, et al.
Published: (2011-09-01)

Uso de misoprostol retal para indução do parto em gestantes com amniorrexe prematura: ensaio clínico fase II Use of rectal misoprostol for induction of labor in patients with premature rupture of membranes: a phase II clinical trial
by: Francisco Carlos Nogueira Arcanjo, et al.
Published: (2003-08-01)

A case report and literature review of myocardial infarction with nonobstructive coronary arteries (MINOCA) possibly due to acute coronary vasospasm induced by misoprostol
by: Nguyen Viet Hau, et al.
Published: (2023-05-01)

Misoprostol as an adjunct to oxytocin can reduce postpartum-haemorrhage: a propensity score–matched retrospective chart review in Bamenda-Cameroon, 2015–2016
by: Frederick Morfaw, et al.
Published: (2019-07-01)

Misoprostol for the prevention of post-partum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development
by: Karen Hobday, et al.
Published: (2020-04-01)

The effect of propranolol plus misoprostol with misoprostol alone on induction of labor
by: Atieh Mohammadzadeh Vatanchi, et al.
Published: (2021-11-01)

Baixas doses de misoprostol vaginal (12,5 versus 25 mcg) para indução do parto a termo Low-dose vaginal misoprostol (12.5 versus 25 µg) for induction of labor at term
by: Francisco Airton Rangel Filho, et al.
Published: (2007-12-01)

Comparison of Vaginal Misoprostol, Combined Letrozole and Misoprostol and Combined Laminaria and Misoprostol in the Preparation of Second-Trimester Cervical Abortion
by: Faiba Kahnamooi, et al.
Published: (2018-01-01)

Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report
by: Nobutaka Chiba, et al.
Published: (2021-02-01)

Association between hyperpyrexia and poststroke outcomes in patients with recanalization after mechanical thrombectomy: a retrospective cohort study
by: Man Chen, et al.
Published: (2021-09-01)